IMPP:NASDAQImperial Petroleum Inc. Analysis
Data as of 2026-04-10 - not real-time
$4.28
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Imperial Petroleum trades well above its 20‑day SMA and comfortably above the 50‑day and 200‑day averages, indicating a short‑term bullish bias, but the MACD line sits below its signal and the histogram is negative, flagging bearish momentum. The stock’s PE ratio hovers around 3× earnings—far below the industry average of roughly 22×—and the price‑to‑book is under 0.4×, while the DCF model suggests a fair value near $45, implying a massive valuation gap. Recent earnings disclosed a 95% year‑over‑year revenue surge and a solid profit margin above 30%, supported by a cash pile of $179 million and zero debt, reinforcing the balance‑sheet strength. However, the 30‑day volatility exceeds 55%, trading volume has been on a downtrend, and the beta is low at about 0.5, reflecting limited market‑wide price sensitivity.
The combination of extreme undervaluation, strong cash generation, and a supportive earnings backdrop points to upside potential, yet the bearish technical signals, shrinking liquidity, and sector‑specific regulatory and commodity‑price headwinds suggest a cautious approach in the near term.
The combination of extreme undervaluation, strong cash generation, and a supportive earnings backdrop points to upside potential, yet the bearish technical signals, shrinking liquidity, and sector‑specific regulatory and commodity‑price headwinds suggest a cautious approach in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD divergence
- Decreasing trading volume
- Proximity to recent support level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Substantial valuation gap (low PE/PB vs DCF)
- Strong cash position and no debt
- Robust revenue growth and profit margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑run cash‑flow potential from shipping contracts
- Sustained low leverage and high liquidity
- Fundamental upside implied by DCF and analyst price targets
Key Metrics & Analysis
Financial Health
Revenue Growth95.10%
Profit Margin31.04%
P/E Ratio3.3
ROE10.51%
ROA4.89%
P/B Ratio0.3
Op. Cash Flow$80.8M
Free Cash Flow$39.9M
Industry P/E21.9
Technical Analysis
TrendBullish
RSI47.0
Support$4.06
Resistance$4.82
MA 20$4.45
MA 50$4.15
MA 200$4.13
MACDBearish
VolumeDecreasing
Fear & Greed Index87.41
Valuation
Fair Value$45.86
Target Price$8.00
Upside/Downside87.13%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.50
Volatility55.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.